We are pleased to announce that the second Allergen Immunotherapy (AIT) module, dedicated to the latest advances, is now published!
This module focuses on the potential economic benefits of AIT, both for the patient and the society. It sheds light on the role of how eHealth technologies can support AIT's prescription, administration and monitoring. This module also provides novel insights into real world evidence (RWE) in AIT and their implications.
We also discuss important and timely topics that are thoroughly examined, such as the combination of AIT and biologicals for long-term effect and sustainability and novel preparations and adjuvants used in AIT. See how symptom assessment of patients might be performed with allergic rhinitis using an Allergen Exposure Chamber.
Discover the latest news about AIT in our new module, led by renowned authorities in the field. Dive into cutting-edge research, novel treatment approaches, and the latest advancements in personalised medicine.
Listen to our five speakers on this important topic!
No comments:
Post a Comment